Biological Containment Isolation System (BCIS)

The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) and Joint Project Manager for CBRN Protection are seeking innovative Biological Containment Isolation System (BCIS) capabilities. This multi-phased prototype project aims to develop negative pressure Multi-Patient BCIS tents/shelters for managing High-Consequence Infectious Disease (HCID) patients in various operational settings. The acquisition strategy involves multiple awards for prototype solutions, with up to three contractors for Phase I and a down-selection to two for Phase II. Successful prototypes must meet stringent requirements, including negative pressure differential, air changes per hour, filtration efficiency, patient access, power, reusability, noise levels, shelf life, and environmental resilience. Proposals should include a master delivery schedule, firm-fixed-price for prototypes, projected unit costs for full-rate production, maximum monthly production rates, and supporting documentation. Deliverables include one prototype for Phase I and three for Phase II, along with various data deliverables such as meeting minutes, test support, integrated master schedule, technical data with unlimited rights preference, Berry Amendment compliance, safety documentation, and manuals. The project emphasizes rigorous testing and evaluation at government facilities, with the potential for non-competitive follow-on production awards for up to 15 units.

This government file addresses questions and answers regarding a federal government Request for Proposal (RFP) for a Collective Protection (CP) system, specifically the BCIS, aiming to modify existing USAF UTS TMT60 tent shelters for negative pressure operation. Key areas covered include cost, data rights (Government Purpose Rights are the minimum), integration with existing systems (modifying TMT60, not replacing CP systems), patient handling (systems are transported without patients, PPTS utilized for infected patients), and production quantities (up to 15 systems). The RFP also discusses Berry Amendment compliance for prototypes, interoperability, decontamination, and procurement via an Army Open Solicitation. Partnering is preferred, especially with Non-Traditional Defense Contractors and small businesses. The timeline indicates a final Call for Solutions (CFS) after April 1st, with submissions due mid-May. The government prioritizes reasonable and allocable costs and substantial non-traditional defense contractor participation. Overall, the document clarifies technical specifications, logistical requirements, and procurement processes for the BCIS project.

The JPM CBRN Protection Industry Day 1-1 Schedule outlines presentations by various companies on Biological Containment Isolation System (BCIS), Portable Patient Transport System (PPTS), and Shipboard Isolation System (SIS). The event, held at MLT Systems in Stafford, VA, features two groups of companies presenting throughout the day. Group 1 includes P2 Mission Solutions, JGW Group Peke Safety LLC, Safe Decon Inc, Knight Aerospace, HDT Global, Valinor, LifePort, LLC, ISOVAC Products, Inspire Rx LLC, EpiGuard AS, and Battelle. Group 2 consists of GUILD ASSOCIATES INC, Stitch Partners LLC, Duke Human Vaccine Institute, Air, Univox LLC, Carecubes Inc., and Salus Worldwide Solutions Corp. This schedule indicates a government-related industry event focused on showcasing solutions for chemical, biological, radiological, and nuclear (CBRN) protection, likely in preparation for future RFPs or procurement opportunities.

The U.S. Army Contracting Command-Aberdeen Proving Ground, on behalf of the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection, issued a Draft Call for Solutions (CFS) for a Biological Containment Isolation System (BCIS). This CFS, W911QY-26-S-BCIS-01, seeks prototype solutions for a deployable biological isolation unit to manage highly contagious infectious disease (HCID) patients in various operational environments. The acquisition follows a two-step process: an initial Solution Brief submission, followed by an invitation for selected offerors to submit a full proposal. Key requirements for the BCIS include negative pressure differential, specific air exchanges, high-efficiency filtration, and reusability, with a strong emphasis on non-traditional/small business participation. The evaluation criteria prioritize technical merit, innovation, IP strategy, and adherence to performance thresholds. The project is anticipated to have two phases, with Phase I delivering one prototype and Phase II delivering three, with the government preferring unlimited data rights.

The Statement of Objectives (SOO) outlines the U.S. government's requirement for a Biological Containment Isolation System (BCIS) to manage High-Consequence Infectious Disease (HCID) patients. The goal is a modular, field-installable kit that converts a standard TMT60 tent into a negative-pressure, multi-patient BCIS shelter. The acquisition will be multi-phased, with up to three contractors selected for Phase I to deliver prototypes for testing, followed by a down-selection to two for Phase II. Successful prototypes must meet stringent criteria for force protection, patient access, modularity, and environmental factors. The government seeks robust data rights and may award a non-competitive follow-on production contract for up to 15 units. Proposals must include a draft Statement of Work, delivery schedules, pricing, production rates, and supporting documentation demonstrating technical maturity and performance.

The U.S. Army Contracting Command has issued a Call for Solutions (CFS) for a Biological Containment Isolation System (BCIS) under an Other Transaction Authority (OTA) for Prototype Projects. The government seeks modular, field-installable kits to convert existing Air Force TMT60 positive pressure tent shelters into negative pressure Multi-Patient BCIS tents for managing highly contagious infectious disease (HCID) patients. The acquisition involves a two-step process: an initial Solution Brief submission by June 9, 2026, followed by a Request for Solution Proposal (RSP) for selected offerors. Evaluation criteria include threshold assertions, OTA eligibility, technical merit, and programmatic viability. The project has two phases, with up to three contractors selected for Phase I to deliver three prototype systems, and up to two proceeding to Phase II to deliver five prototypes. The government prefers Unlimited Rights for intellectual property and will assess data rights assertions. Successful completion of the prototype project may lead to a follow-on production contract without further competition. Key success criteria include maintaining negative pressure, adequate air changes, and filtration efficiency.

The Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Program Executive is seeking innovative Biological Containment Isolation System (BCIS) capabilities. The goal is to develop a modular, field-installable kit to convert the United States Air Force TMT60 tent shelter into a negative pressure, multi-patient BCIS tent. This system will allow medical staff to treat High-Consequence Infectious Disease (HCID) patients while minimizing infection risks to others. The acquisition strategy involves a multi-phased prototype project with up to three contractors for Phase I, followed by a down-selection to two for Phase II. Successful prototypes must meet stringent criteria, including negative pressure differential, air changes per hour, filtration efficiency, and regulatory compliance. The government may award a non-competitive follow-on production contract for up to 15 units after Phase II. Proposals must include a draft Statement of Work, a master delivery schedule, total firm-fixed-price, projected unit cost for full-rate production, and supporting documentation demonstrating technical maturity and performance. The project emphasizes data rights, Berry Amendment compliance, safety documentation, and comprehensive manuals.

The Chemical, Biological, Radiological, and Nuclear Defense (CBRND) program seeks innovative Biological Containment Isolation System (BCIS) capabilities to manage High-Consequence Infectious Disease (HCID) patients. The goal is a modular, field-installable kit converting a standard Air Force TMT60 tent into a negative-pressure, multi-patient BCIS shelter. The acquisition will be multi-phased, with up to three contractors selected for Phase I, followed by a down-selection to two for Phase II. Successful prototypes must meet stringent criteria for force protection, patient access, modularity, and regulatory compliance. The government prefers unlimited data rights and will evaluate proposals based on performance, technical maturity, cost, and risk reduction. Deliverables include three prototypes for Phase I and five for Phase II, along with various data and support documentation.

The document addresses questions from potential bidders for a government contract, likely an RFP, concerning the integration of a Biocontainment Isolation System (BCIS) with the TMT60 tent system. Key information includes the confirmation of posted Q&A responses on sam.gov, specific integration requirements for the 2-door configuration of the TMT60 tent (NSN 8340-01-689-5996), and details on government-provided power (8 kW, 190–240 VAC, 3-Phase, 50/60 Hz) and filtration systems (M98 CBRN filter sets). The government will not provide physical access to the TMT60 but may share the Operator and Maintenance Manual. Internal dimensions are specified (19'0" W x 34'0" L x 6'9" Eave x 9'1" Peak), with a 100 lbs maximum hanging weight limit per attachment point, and pre-installed lighting and power cabling. The proposal submission deadline will not be extended. HEPA-filtered recirculating airflow designs are acceptable if they meet recognized standards. Noise levels must not exceed 65 dBA on primary power and 70 dBA on backup power. The document also outlines specific MIL-STD-461 and MIL-STD-464 requirements for electronic components and system-level evaluations, and clarifies air path travel distance through the containment area volume.

The document addresses questions and answers regarding the integration of BCIS solutions with the TMT60 tent system, which is part of federal government RFPs. It clarifies that responses to questions submitted by April 1, 2026, are available on sam.gov. The BCIS solution must integrate with the standard 2-door configuration of the TMT60 shelter (NSN 8340-01-689-5996), with internal dimensions of 19'0" W x 34'0" L x 6'9" Eave x 9'1" Peak. The government will provide approximately 8 kW of power operating on 190–240 VAC, 3-Phase, 50/60 Hz during evaluation and the TMT60 uses M98 CBRN filter sets. The maximum allowable hanging weight limit for each interior attachment point is 100 lbs. A HEPA-filtered recirculating airflow design is acceptable if it meets recognized standards. The system's noise levels must not exceed 65 dBA on primary power and 70 dBA on backup power. MIL-STD-461 and MIL-STD-464 requirements are specified for electronic components and system-level evaluations. The clean air inlet and filtered exhaust air outlet should be positioned to maximize air path travel. The proposal submission deadline will not be extended. Physical access to a TMT60 shelter will not be provided prior to award.

The U.S. Army Contracting Command-Aberdeen Proving Ground, on behalf of the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection, has issued a Call for Solutions (CFS) under Other Transaction Authority (10 U.S.C. § 4022). This solicitation seeks prototype solutions for a Biological Containment Isolation System (BCIS) to convert positive-pressure United States Air Force TMT60 tent shelters into negative-pressure, multi-patient isolation units for managing highly contagious infectious diseases in austere environments. This acquisition utilizes a phased selection process. In Step 1, interested parties must submit a Solution Brief and a Supporting Data Package by July 10, 2026. Submissions will be evaluated on a pass/fail basis regarding eligibility and threshold force protection requirements (specifically maintaining a -2.5 Pa pressure differential, ≥12 air changes per hour, and 99.97% filtration efficiency), alongside technical merit and programmatic viability. Selected offerors will receive a Request for Solution Proposal (RSP) for Step 2. The government plans to award up to three Phase I prototype contracts for three TRL-6 kits each. Following evaluation, up to two contractors will proceed to Phase II to deliver five TRL-7 kits for operational testing. The government prefers unlimited data rights to support long-term lifecycle sustainment. Successful completion of the prototype phase may lead to a sole-source follow-on production contract. Notably, the government may utilize artificial intelligence tools to assist in analyzing and summarizing the proposals, while retaining all final evaluation judgments.

This Call for Solutions (CFS), issued by the U.S. Army Contracting Command-Aberdeen Proving Ground on behalf of the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection, seeks prototype solutions for a Biological Containment Isolation System (BCIS). Utilizing Other Transaction Authority (OTA) under 10 U.S.C. § 4022, the government aims to acquire a modular, field-installable kit to convert the U.S. Air Force’s positive-pressure Tactical Military Tall 60 (TMT60) tent shelter into a negative-pressure, multi-patient containment system for managing High Consequence Infectious Disease (HCID) outbreaks in austere environments. The acquisition follows a multi-step process. In Step 1, interested parties must submit a two-file Solution Brief and Supporting Data Package by July 7, 2026. Submissions will be evaluated on a pass/fail basis for OTA eligibility and critical threshold requirements (such as -2.5 Pa negative pressure, ≥12 air changes per hour, 99.97% filtration efficiency, and TMT60 compatibility), alongside technical merit and programmatic viability. Selected offerors will proceed to Step 2 to submit a full Request for Solution Proposal (RSP) for a Phase I prototype award. The project anticipates a phased effort: Phase I will award firm-fixed-price agreements to up to three contractors to deliver three TRL-6 prototype kits. Phase II will down-select to up to two contractors to deliver five TRL-7 prototype kits for comprehensive testing. Successful completion of the prototype phase may lead to a non-competitive follow-on production contract. The government prefers unlimited data rights to ensure long-term system sustainment.

This Statement of Objectives (SOO) outlines the requirements for the Biological Containment Isolation System (BCIS) prototype project, managed by the CPE CBRND and Joint Project Manager for CBRN Protection. The goal is to develop a modular, field-installable kit to convert a standard United States Air Force UTS Systems Tactical Military Tall 60 (TMT60) positive pressure tent shelter into a negative pressure, multi-patient isolation facility for managing patients with High-Consequence Infectious Diseases (HCID). The acquisition strategy utilizes a multi-phased Other Transaction Authority (OTA) approach. Phase I will select up to three contractors to deliver three prototypes at Technology Readiness Level (TRL) 6 for government testing and evaluation. Phase II will down-select to up to two contractors to deliver five TRL 7 prototypes for operational demonstrations and training. Successful completion of the prototype phases may lead to a non-competitive follow-on production award of up to 15 units. Key performance thresholds include maintaining a negative pressure differential of -2.5 Pa, achieving at least 12 air changes per hour, utilizing 99.97% efficient filtration, and ensuring the tent remains fully reversible to its original configuration. Contractors must submit a draft Statement of Work (SOW), master delivery schedule, firm-fixed pricing, and data rights assertions. Proposals providing less than Government Purpose Rights may be evaluated negatively. Technical performance, technical maturity, item cost, and risk reduction are the primary evaluation factors.

This document presents a Questions and Answers (Q&A) compilation from a Vendor Day for the federal Biological Containment Isolation System (BCIS) solicitation. It clarifies technical, logistical, and procedural requirements for interested contractors. Key technical details confirm that the overall system is powered by two 100kW generators, and Government Furnished Equipment (GFE) such as the TMT60 tent, a Light Environmental Control Unit (LECU), a Filter Fan Assembly (FFA), and the JECP TKSS Mobile Protective Ensemble (MPE) will be provided as part of the solution. The Government specifies that directional airflow must move in a single direction, internal D-rings must support up to 100 pounds, and the TKSS anteroom must be integrated into proposals. Additionally, the project seeks solutions to prevent shelter floor "mushrooming" under negative pressure. Regarding scheduling and logistics, the transition between Phase 1 and Phase 2 testing is anticipated to have a four-to-five-month gap, with nine months between user evaluations. Contractors must provide on-site technical support for these test events. Finally, despite industry feedback requesting an increase in the maximum production quantity of 15 units to offset prototype development costs, the Government confirmed that the current acquisition and testing requirements stand as written.